Correlation Between CONMED and Sight Sciences
Can any of the company-specific risk be diversified away by investing in both CONMED and Sight Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CONMED and Sight Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CONMED and Sight Sciences, you can compare the effects of market volatilities on CONMED and Sight Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CONMED with a short position of Sight Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of CONMED and Sight Sciences.
Diversification Opportunities for CONMED and Sight Sciences
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between CONMED and Sight is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding CONMED and Sight Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sight Sciences and CONMED is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CONMED are associated (or correlated) with Sight Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sight Sciences has no effect on the direction of CONMED i.e., CONMED and Sight Sciences go up and down completely randomly.
Pair Corralation between CONMED and Sight Sciences
Given the investment horizon of 90 days CONMED is expected to generate 0.55 times more return on investment than Sight Sciences. However, CONMED is 1.81 times less risky than Sight Sciences. It trades about 0.05 of its potential returns per unit of risk. Sight Sciences is currently generating about -0.23 per unit of risk. If you would invest 7,476 in CONMED on August 28, 2024 and sell it today you would earn a total of 278.00 from holding CONMED or generate 3.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
CONMED vs. Sight Sciences
Performance |
Timeline |
CONMED |
Sight Sciences |
CONMED and Sight Sciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CONMED and Sight Sciences
The main advantage of trading using opposite CONMED and Sight Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CONMED position performs unexpectedly, Sight Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sight Sciences will offset losses from the drop in Sight Sciences' long position.CONMED vs. Heartbeam | CONMED vs. EUDA Health Holdings | CONMED vs. Nutex Health | CONMED vs. Healthcare Triangle |
Sight Sciences vs. Si Bone | Sight Sciences vs. Rapid Micro Biosystems | Sight Sciences vs. Tactile Systems Technology | Sight Sciences vs. Pulmonx Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |